A carregar...
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report
Abstract This study presents the first detailed pharmacokinetic data of alectinib and its metabolite M4 in a patient with anaplastic lymphoma kinase (ALK)‐rearranged lung adenocarcinoma undergoing hemodialysis. When the patient was administered a daily 300 mg bid dose of alectinib, the maximal obser...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Wiley
2022-04-01
|
Colecção: | Thoracic Cancer |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1111/1759-7714.14357 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|